Perspective Therapeutics (CATX) Long-Term Investments (2014 - 2016)
Perspective Therapeutics (CATX) posted Long-Term Investments of $3.0 million for Q2 2016, down 42.74% sequentially from $5.2 million in Q1 2016, and down 41.78% YoY from $5.1 million in Q3 2015.
Perspective Therapeutics (CATX) Long-Term Investments (2014 - 2016) Analysis & Trends
Perspective Therapeutics has reported Long-Term Investments for 3 years, with the latest figure at $3.0 million in Q2 2016.
- Quarterly Long-Term Investments fell 41.78% year-over-year to $3.0 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $3.0 million (down 41.78% YoY) and the FY2016 annual result came in at $3.0 million, down 41.78% from the prior year.
- Long-Term Investments retreated to $3.0 million in Q2 2016 per CATX's latest filing, from $5.2 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $5.4 million in Q2 2014 and troughed at $3.0 million in Q2 2016.
- A 3-year average of $4.8 million and a median of $5.2 million in 2015 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2015 and 2016: Long-Term Investments fell 5.45% in 2015, then sank 41.78% in 2016.
- Over 3 years, Long-Term Investments stood at $5.4 million in 2014, then retreated by 4.4% to $5.2 million in 2015, then slumped by 42.42% to $3.0 million in 2016.
- According to Business Quant data, Long-Term Investments over the past three periods registered $3.0 million, $5.2 million, and $5.2 million for Q2 2016, Q1 2016, and Q4 2015 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | - |
| 10 | Perspective Therapeutics | 387.28 Mn | 387.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 2.97 Mn |
| Mar 31, 2016 | 5.19 Mn |
| Dec 31, 2015 | 5.16 Mn |
| Jun 30, 2015 | 5.11 Mn |
| Jun 30, 2014 | 5.40 Mn |